In the nucleus, FOXO4 activates the transcription of genes encoding antioxidant enzymes like manganese superoxide dismutase (MnSOD), catalase (CAT), and glutathione peroxidase (GPX)
[DOI] [PubMed] [Google Scholar] 8.Balenovic D., Bencic M.L., Udovicic M., Simonji K., Hanzevacki J.S., Barisic I., Kranjcevic S., Prkacin I., Coric V., Brcic L., et al
Important Safety Information Contraindications: Active cancer or malignancy (use only with medical supervision) Pregnancy or breastfeeding (insufficient safety data in these populations) Known allergy to peptide compounds Severe uncontrolled medical conditions without physician oversight Monitoring recommendations: While intensive monitoring is not required as with growth hormone, baseline and periodic assessment of body composition, basic metabolic panel, and general health markers ensures optimal results and safety
Less common but serious adverse effects seen in the clinical trials are pancreatitis (inflammation of the pancreas), gallbladder disease (such as gallstones), and worsening of diabetic retinopathy
Research groups have published on growth-hormone-secretagogue stacks such as GHRP-6 paired with a GHRH analog combining fragments for different aspects of the GH axis, on cognitive-research stacks combining nootropic-class peptides with neurotrophic compounds, and on anti-inflammatory stacks combining KPV with other immunomodulatory fragments which is exactly why the KLOW blend was designed with KPV included